2024 annual financial data

Seres Therapeutics 2024 Net margin

Direct answer

Net margin was Not calculable.

Operating income was -121.32M USD and net income was -146.57M USD.
Operating cash flow was -148.61M USD.

Get free Seres Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-121.32M USD
Net income
-146.57M USD
Operating cash flow
-148.61M USD